Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
Abstract
The corona virus disease ‐2019 (COVID‐19) is a recently described infectious disease caused by the severe acute respiratory syndrome corona virus 2 with significant cardiovascular implications. Given the increased risk for severe COVID‐19 observed in adults with underlying cardiac involvement, there is concern that patients with pediatric and congenital heart disease (CHD) may likewise be at increased risk for severe infection. The cardiac manifestations of COVID‐19 include myocarditis, arrhythmia and myocardial infarction. Importantly, the pandemic has stretched health care systems and many care team members are at risk for contracting and possibly transmitting the disease which may further impact the care of patients with cardiovascular disease. In this review, we describe the effects of COVID‐19 in the pediatric and young adult population and review the cardiovascular involvement in COVID‐19 focusing on implications for patients with congenital heart disease in particular.
Formats available
You can view the full content in the following formats:
Information & Authors
Information
Published In
Copyright
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Versions
You are viewing the most recent version of this article.
History
Published online: 22 May 2020
Published in print: 16 June 2020
Keywords
Notes
(J Am Heart Assoc. 2020;9:e017224. https://doi.org/10.1161/JAHA.120.017224.)
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- SARS-CoV-2 Infection and COVID-19 in Children, Rheumatic Disease Clinics of North America, 51, 1, (139-156), (2025).https://doi.org/10.1016/j.rdc.2024.09.003
- COVID-19 Related Multi-System Inflammatory Syndrome in Children (MIS-C): A Systematic Review, Archives of Pediatric Infectious Diseases, 12, 3, (2024).https://doi.org/10.5812/apid-139928
- DOENÇAS INFECCIOSAS NA INFÂNCIA E SEUS AGENTES PATOGÊNICOS QUE CAUSAM INSUFICIÊNCIA CARDÍACA, REVISTA FOCO, 17, 11, (e6812), (2024).https://doi.org/10.54751/revistafoco.v17n11-065
- Cardiovascular complications in COVID-19: acute management, long-term sequelae, and post-acute care strategies: a brief review, InterConf, 50(221), (225-242), (2024).https://doi.org/10.51582/interconf.19-20.10.2024.025
- Impact of COVID-19 Infections among Unvaccinated Patients with Congenital Heart Disease: Results of a Nationwide Analysis in the First Phase of the Pandemic, Journal of Clinical Medicine, 13, 5, (1282), (2024).https://doi.org/10.3390/jcm13051282
- Geospatial analysis of cardiovascular mortality before and during the COVID-19 pandemic in Peru: analysis of the national death registry to support emergency management in Peru, Frontiers in Cardiovascular Medicine, 11, (2024).https://doi.org/10.3389/fcvm.2024.1316192
- COVID-19 sequelae on transthoracic echocardiography findings in pediatric patients with septal congenital heart disease: A retrospective comparative analysis, Heart, Vessels and Transplantation, 0, Ahead of Print, (2024).https://doi.org/10.24969/hvt.2024.486
- ECG based Heart Disease Detection: Current State and Technological Advancements, 2024 15th International Conference on Computing Communication and Networking Technologies (ICCCNT), (1-6), (2024).https://doi.org/10.1109/ICCCNT61001.2024.10725299
- Trends in mortality risk of patients with congenital heart disease during the COVID-19 pandemic, American Heart Journal, 268, (9-17), (2024).https://doi.org/10.1016/j.ahj.2023.11.010
- Viral Infections, Myocarditis, and Autoimmune Heart Disease, Infection and Autoimmunity, (383-403), (2024).https://doi.org/10.1016/B978-0-323-99130-8.00033-7
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.